TAG:
laboratory outreach
Three Blood Brothers Release Year-End Financial Performance
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
FINANCIAL REPORTS RELEASED by the three national laboratories for the fiscal year 1998 reveal a definite improvement in their financial performance and cash flow. One sign of this improvement is the fact that none of the three blood brothers disclosed any huge write-downs similar to those experience…
Washington’s PacLab Network Succeeds With Standardization
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
PART TWO OF TWO PARTS CEO SUMMARY: In part one of this two-part series, we looked at how changes to healthcare in the state of Washington brought about the creation of PacLab Network Laboratories. In this concluding installment, we explore how PacLab is standardizing lab…
Unrealized Gains Targeted By Premier’s Lab Initiative
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: In part one of this exclusive interview, Premier’s John Biggers described the reasons why the 1,700 hospital consortium developed a strategic services program for clinical laboratories. In this final installment, Biggers provides insight as to how the program will work and …
National Labs Show Improved Finances For First Quarter, 1998
By Robert Michel | From the Volume V No. 6 – May 4, 1998 Issue
FIRST QUARTER FINANCIAL performance of the three national laboratories indicates that they may finally be past the worst of the managed care storm. On April 14, Quest Diagnostics Incorporated became the first of the three blood brothers to release earnings. First quarter revenues d…
Consider Tenet-SBCL Deal As Timely Wake-Up Call
By Robert Michel | From the Volume V No. 1 – January 19, 1998 Issue
CEO SUMMARY: Expect the Tenet-SBCL contract announcement to trigger similar deals during the next 18 months. Competition and the need to gain economic advantage will drive some hospital CEOs to turn their laboratories over to commercial laboratory partners. The number of such joint ventur…
Market Forces Cause Detroit’s Lab Network To Launch Operations
By Robert Michel | From the Volume V No. 1 – January 19, 1998 Issue
CEO SUMMARY: Joint Venture Hospital Laboratories’ success rests on an essential fact: it exists to respond to marketplace demands. The network links laboratory operations of 24 hospitals owned by eight integrated delivery systems in Greater Detroit. Not only is it the oldest continuousl…
Louisiana Reference Lab Purchased By Dynacare
By Robert Michel | From the Volume IV No. 18 – December 29, 1997 Issue
CEO SUMMARY: General Health System of Baton Rouge decided to “cash in” the capital value of its consolidated laboratory organization by selling it to Dynacare. It will use the money for other corporate projects. This sales transaction validates that there is still considerable value t…
Quest Announces Major Restructuring for 1998
By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue
CEO SUMMARY: Recognizing the reality of laboratory over-capacity in the marketplace, Quest Diagnostics Incorporated intends to align its laboratory capacity with existing specimen volumes. In so doing, it’s taking a progressive step and moving more aggressively than its two national com…
Consolidation At Presbyterian Encourages Regional Strategy
By Robert Michel | From the Volume IV No. 15 – October 27, 1997 Issue
CEO SUMMARY: Presbyterian Laboratory Services represents one of the more advanced business models of laboratory consolidation found today in the United States. Owned by an integrated delivery system, the laboratory division serves six hospitals and a variety of outreach clients. Several e…
Quest Diagnostics & SmithKline Release Third Quarter Financials
By Robert Michel | From the Volume IV No. 15 – October 27, 1997 Issue
It appears that 1997 will be kinder to Quest Diagnostics Inc. and SmithKline Beecham Clinical Laboratories (SBCL) than the last three years. Both companies reported improved financial results for third quarter and mixed results for year-to-date. As of press time, …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized